ResMed (RMD) 10-K Summary — Year Ended Jun 30, 2023
The filing reports financial results with revenue growth and provides information on liquidity and capital resources. No detailed business overview or risk factors are included in the supplied sections.
Key takeaway
Year ended Jun 30, 2023 · FY2025 10-K
The filing reports financial results with revenue growth and provides information on liquidity and capital resources. No detailed business overview or risk factors are included in the supplied sections.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$4.2B
Revenue reported for the fiscal year.
Operating income
$1.1B
Income from operations reported for the year.
Net income
$897.6M
Net income reported for the year.
Operating cash flow
$693.3M
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2021 | $3.2B | n/a |
| Jun 30, 2022 | $3.6B | +11.9% |
| Jun 30, 2023 | $4.2B | +18.0% |
Business overview
The business overview section of the filing only references other items and does not provide a description of the company's operations. Therefore, no specific business activities are described.
Financial performance
Revenue increased compared to the prior year. Operating income and net income were reported. Operating cash flow was also generated.
Material risks
The risk factors section only references an item number and does not provide any specific risk descriptions in the supplied context. Thus, no material risks are identified.
Liquidity and capital
Principal liquidity sources are cash, operations, and a credit facility, with uses including R&D, marketing, capex, acquisitions, dividends, and debt repayment. Future capital requirements depend on revenue growth, reimbursement, and spending on new products.
What to watch
Monitor the impact of supply chain disruptions and working capital requirements on operating cash flow.